Alpha Aminoadipic Acid

Optimal result: 0 – 2 umol/L

Elevated levels of Alpha Aminoadipic Acid in plasma may be associated with certain inborn errors of amino acid metabolism. These metabolic disorders are caused by genetic defects that affect the synthesis, catabolism, or transport of amino acids, leading to a diverse class of diseases. 

Inborn errors of amino acid metabolism can manifest in various ways and have different clinical presentations. For example, some well-known disorders in this category include Phenylketonuria (PKU), Lysinuric Protein Intolerance (LPI), and Homocystinuria due to Cystathionine Beta-Synthase (CBS) deficiency. Each of these conditions has distinct pathophysiological features and clinical implications.

  • Phenylketonuria is characterized by defects in phenylalanine hydroxylase, leading to the accumulation of phenylalanine.
  • Lysinuric Protein Intolerance results from defects in the transport of certain amino acids, leading to malabsorption and secondary urea cycle defects.
  • Homocystinuria is caused by a defect in cystathionine β-synthase, leading to the accumulation of methionine and homocysteine.

It's important to note that while these conditions are examples of inborn errors of amino acid metabolism, they may not be directly related to elevated Alpha Aminoadipic Acid levels. The specific link between such elevated levels and particular metabolic disorders would require further clinical investigation and correlation with other clinical findings.

Elevated levels of Alpha-Aminoadipic Acid in plasma can also be caused by various conditions, including vitamin B6 insufficiency or pyridoxal 5-phosphate dysfunction. Vitamin B6 is crucial for transaminase enzymes, which convert one amino acid to another and help them enter the Krebs cycle. Therefore, a deficiency in vitamin B6 can lead to an accumulation of Alpha-Aminoadipic Acid.

A potential treatment approach for elevated Alpha-Aminoadipic Acid levels involves supplementing with vitamin B6 and α-KG (alpha-Ketoglutarate). This supplementation aims to facilitate the transamination conversion of Alpha-Aminoadipic Acid to Alpha-Ketoadipic Acid. However, it's important to note that the effectiveness and appropriateness of this treatment can vary depending on the underlying cause and individual health circumstances.

Additionally, there are instances, such as in Pyridoxine-Dependent Epilepsy (PDE), where patients are already on daily pyridoxine supplements. In such cases, treatment approaches can be more complex and tailored to the specific disorder and patient needs.

Given the complexity and potential variability in underlying causes, it's essential to consult a healthcare provider for an accurate diagnosis and appropriate treatment plan tailored to the individual's specific condition and overall health profile.

Amino Acid Analysis, Plasma - Amino Acid analysis is necessary for the diagnosis of a variety of inborn errors of metabolism. These include, but are not limited to, phenylketonuria, tyrosinemia, citrullinemia, non-ketotic hyperglycinemia, maple syrup urine disease, and homocystinuria. The assay is also key for the continued monitoring of treatment plans for these disorders and useful for assessing nutritional status of patients.

Amino Acid Analysis, Plasma - Amino Acid analysis is necessary for the diagnosis of a variety of inborn errors of metabolism. These include, but are not limited to, phenylketonuria, tyrosinemia, citrullinemia, non-ketotic hyperglycinemia, maple syrup urine disease, and homocystinuria. The assay is also key for the continued monitoring of treatment plans for these disorders and useful for assessing nutritional status of patients.

Alpha-aminoadipic acid (a-Aminoadipic acid) is an intermediary metabolite of lysine (primarily) and of tryptophan.

Alpha-aminoadipic acid also is a metabolite of yeast/fungi metabolism, and anecdotal evidence supports occasional increases with intestinal dysbiosis as a source.

In Reye’s syndrome, alpha-aminoadipic hyperaminoaciduria occurs together with hyperlysinuria. Rare metabolic and acute alpha-aminoadipic hyperaminoaciduria is documented as due to a hereditary defect in the Alpha-aminoadipic acid transaminase enzyme and in the next enzyme in the sequence, alpha-ketoadipic acid dehydrogenase.

In glutaric acidemia/aciduria there can be notable alpha-aminoadipic hyper-aminoaciduria due to a hereditary weakness of glutaryl CoA dehydrogenase. Riboflavin insufficiency as FAD may provoke or worsen alpha-aminoadipic hyperaminoaciduria (and glutaric acidosis) if the dehydrogenase enzymes are weak, but riboflavin may or may not improve the kinetics of defective dehydrogenases.

Alpha Aminoadipic Acid
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Alpha Aminoadipic Acid — 10,000+ markers explained
One Alpha Aminoadipic Acid result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro